[go: up one dir, main page]

ATE140034T1 - Koagulationsassays und reagenzien - Google Patents

Koagulationsassays und reagenzien

Info

Publication number
ATE140034T1
ATE140034T1 AT91907936T AT91907936T ATE140034T1 AT E140034 T1 ATE140034 T1 AT E140034T1 AT 91907936 T AT91907936 T AT 91907936T AT 91907936 T AT91907936 T AT 91907936T AT E140034 T1 ATE140034 T1 AT E140034T1
Authority
AT
Austria
Prior art keywords
platelet
reagents
disclosed
bleeding
factor
Prior art date
Application number
AT91907936T
Other languages
English (en)
Inventor
Roy E Speck
Original Assignee
Analytical Control Syst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analytical Control Syst Inc filed Critical Analytical Control Syst Inc
Application granted granted Critical
Publication of ATE140034T1 publication Critical patent/ATE140034T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT91907936T 1990-04-17 1991-04-15 Koagulationsassays und reagenzien ATE140034T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51017890A 1990-04-17 1990-04-17

Publications (1)

Publication Number Publication Date
ATE140034T1 true ATE140034T1 (de) 1996-07-15

Family

ID=24029678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91907936T ATE140034T1 (de) 1990-04-17 1991-04-15 Koagulationsassays und reagenzien

Country Status (8)

Country Link
US (3) US5451509A (de)
EP (1) EP0525035B1 (de)
JP (1) JPH05506309A (de)
AT (1) ATE140034T1 (de)
AU (1) AU663683B2 (de)
CA (1) CA2040599A1 (de)
DE (1) DE69120674T2 (de)
WO (1) WO1991016453A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569590A (en) * 1990-04-17 1996-10-29 Analytical Control Systems, Inc. Initial screen for abnormal platelet condition
JPH05506309A (ja) * 1990-04-17 1993-09-16 アナリティカル・コントロール・システムズ・インコーポレーテッド 凝固アッセイおよび試薬
US6114135A (en) * 1991-11-08 2000-09-05 Goldstein; Sheldon Multiple coagulation test system and method of using a multiple coagulation test system
US5366869A (en) * 1991-11-08 1994-11-22 Sheldon Goldstein Multiple coagulation test device and method
EP0570356B1 (de) * 1992-05-15 1999-02-17 IMMUNO Aktiengesellschaft Reagens zur Bestimmung der aktivierten partiellen Thromboplastinzeit (aPTT)
US5637452A (en) * 1992-10-02 1997-06-10 Analytical Control Systems, Inc. Kit for an initial screen for abnormal platelet condition comprising propyl gallate or tannin and a metal ion
AU674265B2 (en) * 1993-11-04 1996-12-12 Dade Behring Inc. Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
DE4429660B4 (de) * 1994-08-20 2004-02-12 Dade Behring Marburg Gmbh Zusatzmittel für diagnostische Tests zur Bestimmung der Gerinnungsfähigkeit des Blutes, Verfahren zur Reduzierung der Beeinflussung von diagnostischen Tests durch Heparin und Verwendung von Metallsalzen zu diesen Zwecken
US5731212A (en) * 1994-12-20 1998-03-24 International Technidyne Corporation Test apparatus and method for testing cuvette accommodated samples
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6221672B1 (en) * 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
DE19734648A1 (de) * 1997-08-11 1999-02-18 Dade Behring Marburg Gmbh Verwendung von Annexinen als Lupus Antikoagulans Kontrolle oder Standard in Gerinnungstesten
CA2223562A1 (fr) 1997-12-02 1999-06-02 Hydro-Quebec Nouveaux materiau d'electrodes derives de composes ioniques poly uinoniques, leurs utilisations comme dans les generateurs electrochimiques
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
US6245573B1 (en) * 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
GB9901504D0 (en) * 1999-01-22 1999-03-17 Gray Charles R W Accelrrated whole blood clotting time (A.W.B.C.T.)
AU774889B2 (en) 1999-02-04 2004-07-08 Biomerieux, Inc. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
JP2003524187A (ja) * 2000-02-23 2003-08-12 ベッスト−テスト アンパーツゼルスカブ 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
JP4526152B2 (ja) * 2000-03-08 2010-08-18 シスメックス株式会社 プロトロンビン時間測定試薬
DE10013377A1 (de) * 2000-03-17 2001-09-20 Dade Behring Marburg Gmbh Induzierte Aggregation und Agglutination von Plättchen
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
EP1370874A2 (de) * 2001-01-24 2003-12-17 Accumetrics, Inc. Verfahren zur bestimmung der plättchen-aktivität unter verwendung von anti-plättchen-zusammensetzungen
FR2822462B1 (fr) * 2001-03-23 2005-07-15 Stago Diagnostica Composes activateurs de la coagulation endogene utilisation pour l'exploration de la coagulation endogene
US6891077B2 (en) * 2001-07-25 2005-05-10 The United States Of America As Represented By The Secretary Of The Army Fibrinogen bandages and arterial bleeding models and methods of making and using thereof
CA2475761C (en) * 2002-02-11 2011-07-12 Gold-T Tech, Inc. An implantable device which provides high frequency ultrasound energy to provide acoustical streaming to prevent thrombus formation
US7071001B2 (en) 2003-01-10 2006-07-04 Dnk Associates, Inc. System and method for in vitro bleeding time testing
WO2008144290A2 (en) 2007-05-15 2008-11-27 Pitco Frialator, Inc. Continuously operating filtering apparatus
US8372343B2 (en) 2007-12-07 2013-02-12 Sheldon Goldstein Multiple coagulation test cartridge and method of using same
DE102008008537A1 (de) * 2008-02-06 2009-08-13 Beiersdorf Ag Wundversorgungsartikel
DE102008008540A1 (de) * 2008-02-07 2009-08-13 Beiersdorf Ag Hautpflegezubereitung zur Pflege von gestresster Haut
JP5911345B2 (ja) * 2012-03-27 2016-04-27 シスメックス株式会社 凝固時間測定用試薬、凝固時間測定用試薬キットおよび凝固時間の測定方法
JP6499488B2 (ja) * 2015-03-31 2019-04-10 学校法人東日本学園 凝固時間の測定方法、ループスアンチコアグラントの存否の判定方法及びループスアンチコアグラント検出用試薬キット
JP6595247B2 (ja) * 2015-07-30 2019-10-23 シスメックス株式会社 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
JP2017049040A (ja) * 2015-08-31 2017-03-09 シスメックス株式会社 活性化部分トロンボプラスチン時間測定用試薬、活性化部分トロンボプラスチン時間測定用試薬キットおよび活性化部分トロンボプラスチン時間の測定方法
CN107746804A (zh) * 2017-11-28 2018-03-02 世纪亿康（天津）医疗科技发展有限公司 针对添加肝素血液样本的凝血及血小板功能检测试剂盒及其应用
CN108279313B (zh) * 2017-12-29 2021-03-02 广州万孚生物技术股份有限公司 快速检测血液粘弹性的试剂及测试杯
CN109596599A (zh) * 2019-02-01 2019-04-09 上海出入境检验检疫局动植物与食品检验检疫技术中心 一种油脂中没食子酸丙脂的拉曼光谱快速检测方法
US10429377B1 (en) 2019-03-15 2019-10-01 Coagulation Sciences Llc Coagulation test device, system, and method of use
WO2025172747A1 (en) * 2024-02-14 2025-08-21 Ethicon, Inc. Flowable paste with ellagic acid-nickel complex and uses thereof for activating coagulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1474709A (fr) * 1964-01-22 1967-03-31 Procédé de préparation d'un complexe boro-tannique stabilisé et produit en résultant
US3486981A (en) * 1965-03-15 1969-12-30 Roy E Speck Substances relating to testing of blood-coagulation
US3886066A (en) * 1972-11-06 1975-05-27 Du Pont Tannin treatment for non-porous semipermeable membranes
DE2915310A1 (de) * 1979-04-14 1980-10-30 Behringwerke Ag Neues partielles thromboplastin und dessen verwendung
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
US4455377A (en) * 1982-05-07 1984-06-19 Cooper Laboratories, Inc. Clotting assay and reagent therefor
US4582807A (en) * 1982-07-30 1986-04-15 Natteri Veeraraghavan Cultivation medium for mycobacteria and use thereof
US4490399A (en) * 1983-04-15 1984-12-25 Corning Glass Works Process and compositions for removing tannins from wine
DE3504405A1 (de) * 1985-02-08 1986-08-14 Boehringer Mannheim Gmbh, 6800 Mannheim Bestimmung von prokallikrein
US4666831A (en) * 1985-02-19 1987-05-19 The Liposome Company, Inc. Lipid-dependent diagnostic assays
CA1313997C (en) * 1986-04-11 1993-03-02 Hideo Anraku Accelerator of the activity of hydrolase
JPS63185398A (ja) * 1986-09-10 1988-07-30 Nippon Zoki Pharmaceut Co Ltd 生理活性物質測定法
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
US5055412A (en) * 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
US5039617A (en) * 1989-04-20 1991-08-13 Biotrack, Inc. Capillary flow device and method for measuring activated partial thromboplastin time
US5091304A (en) * 1989-08-21 1992-02-25 International Technidyne Corporation Whole blood activated partial thromboplastin time test and associated apparatus
JPH05506309A (ja) * 1990-04-17 1993-09-16 アナリティカル・コントロール・システムズ・インコーポレーテッド 凝固アッセイおよび試薬
CA2073353C (fr) * 1990-11-14 2003-10-28 Alexandre Zysman Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes

Also Published As

Publication number Publication date
JPH05506309A (ja) 1993-09-16
DE69120674D1 (de) 1996-08-08
DE69120674T2 (de) 1996-11-07
US5451509A (en) 1995-09-19
US5709889A (en) 1998-01-20
AU7689991A (en) 1991-11-11
EP0525035A1 (de) 1993-02-03
WO1991016453A1 (en) 1991-10-31
AU663683B2 (en) 1995-10-19
US5700634A (en) 1997-12-23
EP0525035A4 (en) 1993-10-27
CA2040599A1 (en) 1991-10-18
EP0525035B1 (de) 1996-07-03

Similar Documents

Publication Publication Date Title
ATE140034T1 (de) Koagulationsassays und reagenzien
Mellion et al. Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
Spaet et al. Studies on the mechanism whereby platelets are clumped by adenosine diphosphate
EP2677037B1 (de) Gleichzeitige Messung der Thrombinerzeugung und Gerinnselfestigkeit in Plasma und im gesamten Blut
ES2073908T3 (es) Metodo para determinar la concentracion de anticoagulante.
JPH03236798A (ja) 血しょうおよび血液の内因性トロンビンポテンシャルの測定方法と同方法に使用するキット
US3418083A (en) Hydrophobic test strip for analyzing whole blood
DE3607559A1 (de) Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
Correia-da-Silva et al. Dual anticoagulant/antiplatelet persulfated small molecules
EP0123883B1 (de) Verfahren zur fotometrischen Bestimmung der aktivierten partiellen Thromboplastinzeit und Reagenz dazu
Laurell Influence of dextran on the conversion of fibrinogen to fibrin
Pabinger-Fasching et al. High levels of plasma protein C in nephrotic syndrome
Taugner The effects of univalent anions on catecholamine fluxes and adenosine triphosphatase activity in storage vesicles from the adrenal medulla
Cumming et al. In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins
JP3939771B2 (ja) 血液凝固性の測定用診断試験のための添加剤
Tocantins Influence of the contacting surface on the coagulability and anticephalin activity of normal and hemophilic plasmas
GB1562808A (en) In vitro method
Barbui et al. Electroimmunoassay of plasma subunits-A and-S in a case of congenital fibrin stabilizing factor deficiency
Speck Coagulation assays and reagents
Walker et al. The molecular mechanisms of heparin action: II. Separation of functionally different heparins by affinity chromatography
Von Kaulla et al. On structure-related properties of synthetic organic clot-dissolving (thrombolytic) compounds
Fiedel et al. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protein
Huo et al. A preferential inhibition by Zn2+ on platelet activating factor-and thrombin-induced serotonin secretion from washed rabbit platelets
FI107409B (fi) Protrombiinifragmenttien käyttö
GB2051103A (en) Heparin fractions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties